Acadian Asset Management’s Apyx Medical APYX Stock Holding History

Acadian Asset Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$185K	Buy	51,410 +12,627	+33%	+$47.2K	﹤0.01%	1612
2025 Q4	$131K	Buy	+38,783	New	+$135K	﹤0.01%	1616
2023 Q2	–	Sell	-4,458	Closed	-$12K	–	1717
2023 Q1	$12K	Sell	4,458 -225,916	-98%	-$660K	﹤0.01%	1680
2022 Q4	$537K	Buy	+230,374	New	+$703K	﹤0.01%	1014
2021 Q4	–	Sell	-4,508	Closed	-$62K	–	1661
2021 Q3	$62K	Buy	+4,508	New	+$47.4K	﹤0.01%	1526
2019 Q2	–	Sell	-66,069	Closed	-$417K	–	1770
2019 Q1	$417K	Sell	66,069 -27,494	-29%	-$213K	﹤0.01%	1146
2018 Q4	$607K	Buy	93,563 +61,705	+194%	+$374K	﹤0.01%	858
2018 Q3	$226K	Buy	+31,858	New	+$177K	﹤0.01%	1058
2018 Q2	–	Sell	-9,328	Closed	-$27K	–	1687
2018 Q1	$27K	Buy	+9,328	New	+$24K	﹤0.01%	1454

Other funds holding APYX

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Acadian Asset Management's APYX Position: Q1 2026 in Review

Acadian Asset Management increased its Apyx Medical (APYX) stake by 33% in Q1 2026, buying an estimated $47.2K and bringing the position to 51,410 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Acadian Asset Management first reported a position in APYX in Q1 2018 and has held it in 9 quarters since. The position peaked at $607K in Q4 2018. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

Acadian Asset Management held 51,410 shares of Apyx Medical worth $185K as of Q1 2026.
Acadian Asset Management bought 12,627 Apyx Medical shares in Q1 2026, an estimated $47.2K.
Apyx Medical made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1612 holding.
Acadian Asset Management first reported a position in Apyx Medical in Q1 2018 and has held it in 9 quarters since.
Acadian Asset Management's Apyx Medical position peaked at $607K in Q4 2018.
67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.